Paraoxonase 192 Gln→Arg Polymorphism
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (6) , 1459-1464
- https://doi.org/10.1161/01.str.0000016928.60995.bd
Abstract
Background and Purpose — The etiology of arterial ischemic stroke (AIS) in the young remains unknown in one third of patients. Serum paraoxonase (PON1) is an HDL-associated esterase that hydrolyzes products of lipid peroxidation and prevents the oxidation of LDL. Two common polymorphisms in the PON1 gene, the 192 Gln (Q) → Arg (R) and 55 Leu (L) → Met (M) substitutions, determine interindividual variation in PON1 activity. The association of these polymorphisms with the risk of AIS remains controversial. Methods — We analyzed 118 patients (64 women) with a first nonfatal AIS occurring Results — The prevalence of the PON1 192RR genotype ( P =0.006) and the frequency of the R allele ( P =0.010) were significantly increased among young AIS patients compared with controls. After adjustment for conventional vascular and prothrombotic risk factors, the 192RR genotype remained independently associated with a 4-fold increase in the risk of AIS (odds ratio=4.1; 95% CI, 1.14 to 14.73). Subanalyses stratified by the presence of vascular risk factors and ethnicity did not significantly modify the effect of the PON1 192 polymorphism on AIS risk. No significant differences were found between patients and controls regarding the PON1 55 polymorphism. Conclusions — These findings suggest that the PON 192RR genotype is independently associated with an increased risk of nonfatal AIS among young adults. Further studies are necessary to understand better the mechanistic implications of these observations in the development of AIS in the young.Keywords
This publication has 24 references indexed in Scilit:
- Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetesExperimental and Clinical Endocrinology & Diabetes, 2001
- The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart diseaseAtherosclerosis, 2000
- Mutations in the human paraoxonase 1 genePharmacogenetics, 1999
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- The Paraoxonase Glutamine/Arginine Polymorphism and Cerebrovascular DiseaseCerebrovascular Diseases, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Stroke in the young: incidence and pattern in Benghazi, LibyaActa Neurologica Scandinavica, 1986